Taro pharmaceutical industries ltd (TARO)
CashFlow / Quarterly
Mar'12Mar'11
Cash flows from operating activities:
Net income

47,403

25,953

Adjustments required to reconcile net income to net cash provided by operating activities:
Depreciation and amortization

4,598

4,709

Change in deferred charges and other assets

8

5

Share-based compensation expense

-

20

Accrued severance pay and other long-term liabilities, net

-210

-

Change in derivative instruments, net

3,392

831

Effect of exchange differences on intercompany balances

-2,104

-368

Decrease in long-term debt due to currency fluctuations

814

1,136

Deferred income taxes, net

4,075

3,917

(Increase) decrease in trade receivables, net

-9,879

8,270

Decrease (increase) in other receivables, prepaid expenses and other

535

2,088

Increase in inventories, net

1,583

1,592

Decrease in long-term receivables, prepaid expenses and other

-53

-73

Decrease (increase) in income tax receivables

-

-158

Increase (decrease) in trade payables

-521

939

Decrease in other accounts payable and accrued expenses

3,241

1,615

Increase (decrease) in income tax payables

12,138

-777

Loss on sale of long-lived assets

-22

-

Accrued severance pay and other long-term liabilities, net

-

241

Net cash provided by operating activities

78,094

24,358

Cash flows from investing activities:
Purchase of property, plant and equipment

1,610

887

Proceeds from (investment in) short-term bank deposits, net

-18,045

10,105

Proceeds from restricted bank deposits

4,014

-

Proceeds from (investment in) long-term deposits and other assets

-18

-

(Investment in) proceeds from marketable securities, net

-4,909

-

Proceeds from sale of long-lived assets

28

-

Net cash used in investing activities

15,586

-10,992

Cash flows from financing activities:
Proceeds from issuance of shares, net

7

8,554

Repayment of short-term bank debt, net

-

2,428

Proceeds from long-term debt

6,595

-9

Net cash used in financing activities

-6,588

10,991

Effect of exchange rate changes on cash and cash equivalents

1,173

371

(Decrease) increase in cash and cash equivalents

88,265

24,728

Supplemental disclosure of cash flow transactions:
Cash paid during the year for:
Interest

216

95

Income taxes

1,039

3,140

Non-cash investing transactions:
Purchase of property, plant and equipment included in accounts payable

633

464